Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid

Bisphosphonates (BP) are a type of drug known to inhibit bone resorption through complex interventions. Their primary mechanism of action is aimed at the cellular level, inhibiting osteoclast activity and so bone resorption. BPs are widely used, with many patients receiving continuous treatment for...

Descripción completa

Detalles Bibliográficos
Autores principales: Marín-Fernández, Ana-Belén, García Medina, Blas, Aguilar-Salvatierra, Antonio, Jiménez-Burkhardt, Alberto, Gómez-Moreno, Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554249/
https://www.ncbi.nlm.nih.gov/pubmed/26330946
http://dx.doi.org/10.4317/jced.52234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554249/
https://www.ncbi.nlm.nih.gov/pubmed/26330946
http://dx.doi.org/10.4317/jced.52234

Ejemplares similares